InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Anstice David W, 董事. Director active across 1 company, notably Alkermes plc.. Cumulatively, 5 filings have been published. History available since 20 May 2021. The latest transaction was disclosed on 1 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Anstice David W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
7,585 股Ordinary SharesSEC:0001127602-22-017632:0
5,578 股Ordinary SharesSEC:0001127602-21-030300:0
20,000 股@ US$14.6080.5% 占其流量Ordinary SharesSEC:0001127602-21-021239:0
5,000 股@ US$14.6019.5% 占其流量Ordinary SharesSEC:0001127602-21-019456:0
6,104 股0Ordinary SharesSEC:0001127602-21-017782:0
5 条申报中的 5 条
About Anstice David W
David W. Anstice is a Board Member at Alkermes plc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. Alkermes is a biopharmaceutical company specializing in the development of treatments for psychiatric diseases. Mr. Anstice's experience in the pharmaceutical sector is an asset for the company.
